Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAT1 vs Calcipotriol in Plaque Psoriasis
NCT03848806Phase 2Completed
- Sponsor
- Haus Bioceuticals
- Start
- Feb 2016
- Primary completion
- Jul 2016
- Modality
- Botanical Extract, Emollient
01
Overview
Phase 2, randomised, double-blind trial of Metaderm in plaque psoriasis (2 arms), sponsored by Haus Bioceuticals. Primary endpoint: Percentage of patients who achieve a Psoriasis Area and Severity Index (PASI) 75 response at 12 weeks. Started Feb 2016; status: completed.
02
Drugs
Metaderm
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03848806.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03848806.